Resources Category: CME

Presented in February 2019 by: Sharmila Dorbala, MD, MPH, FASNC; Ronald M. Witteles, MD; Mazen Hanna, MD; and Martha Grogan, MD,

Presented in March 2019 by: Sharmila Dorbala, MD, MPH, FASNC; Jamieson Bourque, MD; Frederick Ruberg, MD; and Wael Jaber, MD.

Presented in May 2019 by: Sharmila Dorbala, MD, MPH, FASNC; Prem Soman, MD, MASNC; Rodney Falk, MD; and Mathew Maurer, MD.

The first part of this course focuses on the epidemiology and clinical presentations of cardiac amyloidosis, the clinical burden and impact of delayed diagnosis. The second part focuses on patient assessments and diagnosis of amyloidosis, as well as the latest advances in treatment for hATTR.

Amyloidosis may present in a wide variety of ways, posing challenges to its diagnosis and treatment. This activity will address the different types of cardiac amyloidosis, the clinical manifestations of hATTR amyloidosis, and present treatment strategies based on the most recent clinical data. Release date: Oct 15 2018, Expiration date: Oct 14, 2019

ARC and Medscape have created this CME course, the goal of this activity is to increase awareness of the pathologic features among the different types of systemic amyloidoses and how to accurately diagnose the disease. Presented by Maria M. Picken, MD, PhD   Released: 12/22/2018. Valid for credit through: 12/22/2019      

Dr. Khella discusses diagnosis, treatment and management of patients with hereditary ATTR amyloidosis. Expert Commentary, Jul 25, 2017.  Credits: CME - 0.50 / ABIM MOC - 0.5

Dr. Morie Gertz discusses the symptoms, challenges of diagnosis and emerging treatments for light-chain amyloidosis. Expert Commentary, Sep 8, 2017.  Credits: 0.25 CME / 0.25 ABIM MOC